N/A [49-53] Weak for Reviewed, New- added a Strength of Recommendation columns: Refer to the Grading Recommendations section for more information on how the strength of the recommendation was determined using GRADE methodology. b Evidence column: The first set of references listed in each row in the evidence column constitutes the evidence base for the recommendation. To be included in the evidence base for a recommendation, a reference needed to be identified through the evidence review carried out as part of this guideline update or included in the evidence base for the 2014 VA/DoD HTN CPG. The second set of references in the evidence column (called Additional References ) includes references that provide additional information related to the recommendation, but which were not systematically identified through a literature review. These references were not included in the evidence base for the recommendation and therefore did not influence the strength and direction of the recommendation. c Recommendation Categorization column: Refer to the Recommendation Categorization section for more information on the description of the categorization process and the definition of each category. Recommendation 2014 Strength of Recommendation Evidence 2020 Strength of Recommendation Recommendation Category 6. For all patients, including those with type 2 diabetes, we suggest treating to a systolic blood pressure goal of <130 mm Hg. N/A Additional References: Weak for Reviewed, New- added 7. For patients 60 years and over, we recommend treating to a systolic blood pressure goal of <150 mm Hg with added benefit to lowering systolic blood pressure further for those between 130 mm Hg and 150 mm Hg. Strong For, Strong for Additional References: Strong for Reviewed, Amended 8. 